Evidence-driven therapy and assessment portfolio powered by medical-grade software, tailored interactive content, and proprietary peripherals
Next-generation evidence-based, protocolised therapies designed for true restoration of motor, cognitive and cardiovascular function following neural injuries, degeneration & ageing
Therapies & technologies that enable clinicians to maximise the delivery of motor and cognitive neurorehabilitation across the continuum of care
Diversified digital assessments for high fidelity, reliable quantification of motor and cognitive recovery in patients
Pioneering teleneurorehabilitation from the comfort of home
The MindMotion™ GO programme is helping neurological patients globally access therapy from the comfort and safety of their homes. The international programme is in leading sites across the US and Europe – including Mount Sinai Abilities Research Center, Johns Hopkins, the Royal Buckinghamshire Hospital, and PhysioFunction.
Creating the universal platform for brain recovery and learning
Combining our pioneering digital therapeutics, with state-of-the-art motion analytics, cloud and AI technologies and innovative peripherals, we’re creating the universal solution for brain health. A scalable platform that’s adaptable to all clinical and patient needs, it will transform neurorehabilitation as we know it.
Our novel digital therapies are the future of brain repair
Our novel digital therapies are fully immersive worlds that offer patients scientifically rigorous and emotionally engaging experiences to enhance their neurorehabilitation.
“By decoding the mysteries of the brain, we are not only transforming the lives of people with neurological conditions, but the world as we know it.”
Tej Tadi, Founder, MindMaze
“Life’s improved a lot since I started using MindMotion GO”
“When I go up a level, I can see my effort is paying off”
“It gives me confidence, enjoyment, to do things I could do before my stroke”
Deployed in leading centres around the world, our commercially available digital therapeutics are having a profound impact on the lives of patients and caregivers alike.
years of cutting-edge brain technology innovations
DTX Rx by 2026
Issued and pending patents owned by MindMaze
Indications including Stroke, Parkinson’s, TBI, MCI
Papers. conference proceedings, trials, studies
of its kind CAT 3 code
MindMaze Labs applies advanced neuroscience to everyday life
From F1 teams to fashion houses and electronics firms, we are partnering with leading global brands to create innovative products that bring our neuroscience expertise to new audiences.